Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D.P. Levine.
Vancomycin: a history.
Clin Infect Dis, 42 (2006), pp. S5-S12
[2.]
M.E. Stryjewski, L.A. Szczech, D.K. Benajmin Jr, J.K. Inrig, Z.A. Kanafazi, J.J. Engemann, et al.
Use of Vancomycin or first-generation cephalosporins for the treatment of hemodyalisis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Clin Infect Dis, 44 (2007), pp. 190-196
[3.]
J.F. Mohr, B.E. Murray.
Point: vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant S.aureus.
Clin Infect Dis, 44 (2007), pp. 1543-1548
[4.]
S. Deresinski.
Counterpoint: vanmcomycin and Staphylococcus aureus- an antibiotic enters obsolescence.
Clin Infect Dis, 44 (2007), pp. 1543-1548
[5.]
G. Wang, J.F. Hindler, K.W. Ward, D.A. Bruckner.
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.
J Clin Microbiol, 44 (2006), pp. 3883-3886
[6.]
F.C. Tenover, R.C. Mollering Jr.
The rational for revising the clinical and laboratory Standards Institute vancomycion minimum inhibitory concentration interpretative criteria for Staphylococcus aureus.
Clin Infect Dis, 44 (2007), pp. 1208-1215
[7.]
Clinical and Laboratory Standards Institute.
Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. Standard M100-S17.
Clinical and Laboratory Standards Institute, (2007),
[8.]
Clinical and Laboratory Standards Institute.
Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. Standard M100-S16.
Clinical and Laboratory Standards Institute, (2006),
[9.]
L.K. Hidayat, D.I. Hsu, R. Quist, K.A. Shriner, A. Wong-Beringer.
High dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Arch Intern Med, 166 (2006), pp. 2138-2144
[10.]
American Thoracic Society, Infectious Diseases Society of America.
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healtcare associated pneumonia.
Am J Respir Crit Care Med, 171 (2005), pp. 388-416
[11.]
US Food and Drug Administration, Anti-Infective drugs Advisory Committee Briefing information: Cubist Pharmaceuticals, Inc. Cubicin [accedido 30 Abr 2007]. Disponible en: http://www.fda.gov/cder/foi/nda/2003/21-572_Cubicin.htm
[12.]
M.N. Jeffres, S.T. Micek, W. Isakow, et al.
Increased incidence of nephrotoxicity with higher vancomycin serum trough concentrations [abstract K-789].
Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and chemotherapy (San Francisco), pp. 376
[13.]
F. Chaves Sánchez, M. Daskalaki, J.R. Otero.
Epidemiología de las infecciones por grampositivos multirresistentes.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 4-12
[14.]
G. Moran, A. Krishhnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, R.B. Carey, On behalf of the EMERGENCY ID Net Study Group, et al.
Methicillin- resistant S. aureus.
N Engl J Med, 355 (2006), pp. 666-674
[15.]
C. Pigrau, J. Barberan.
Infecciones cutáneas por grampositivos multirresistentes.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 21-30
[16.]
J.M. Buck, K. Como-Sabetti, K.H. Harriman, R.N. Danila, D.L. Boxrud, A. Glennen, et al.
Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003.
Emerg Infect Dis, 11 (2005), pp. 1532-1538
[17.]
F. Soriano.
Nuevos antibióticos frente a grampositivos.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 13-20
[18.]
J. Cobo.
Papel de los grampositivos en las infecciones osteoarticulares.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 31-43
[19.]
B. Almirante.
Bacteriemia e infecciones endovasculares por grampositivos. Nuevas opciones terapéuticas.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 44-52
[20.]
T. Lisboa, J. Rello.
Neumonía nosocomial por grampositivos.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 53-60
[21.]
A. Burillo, E. Bouza.
Papel de las bacterias grampositivas en la infección abdominal.
Enferm Infecc Microbiol Clin, 25 (2007), pp. 61-68
Copyright © 2008. Elsevier España S.L.. Todos los derechos reservados
